NAGE
Niagen Bioscience
NAGE
NAGE
62 hedge funds and large institutions have $15M invested in Niagen Bioscience in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 28 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
41% less capital invested
Capital invested by funds: $25.3M → $15M (-$10.3M)
68% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 28
81% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 16
Holders
62
Holding in Top 10
1
Calls
$48K
Puts
$54K
Top Buyers
| 1 | +$93K | |
| 2 | +$60.1K | |
| 3 | +$40.2K | |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
+$34K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$34K |
Top Sellers
| 1 | -$955K | |
| 2 | -$693K | |
| 3 | -$392K | |
| 4 |
Goldman Sachs
New York
|
-$371K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$192K |